Zhejiang Jolly Pharmaceutical Co.,LTD (300181.SZ)
CNY 15.66
(-1.39%)
CNY 15.66
(-1.39%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 382.93 Million CNY | 40.27% |
| 2022 | 273 Million CNY | 52.17% |
| 2021 | 179.4 Million CNY | 102.03% |
| 2020 | 88.8 Million CNY | 246.98% |
| 2019 | 25.59 Million CNY | 23.33% |
| 2018 | 20.75 Million CNY | -54.03% |
| 2017 | 45.14 Million CNY | -37.32% |
| 2016 | 72.02 Million CNY | -15.04% |
| 2015 | 84.77 Million CNY | -17.84% |
| 2014 | 103.18 Million CNY | 27.39% |
| 2013 | 80.99 Million CNY | 30.64% |
| 2012 | 62 Million CNY | 21.75% |
| 2011 | 50.92 Million CNY | 22.79% |
| 2010 | 41.47 Million CNY | 31.32% |
| 2009 | 31.58 Million CNY | 89.78% |
| 2008 | 16.64 Million CNY | 19.78% |
| 2007 | 13.89 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 153.63 Million CNY | 7.88% |
| 2024 Q3 | 125.42 Million CNY | -18.36% |
| 2024 Q1 | 142.41 Million CNY | 48.24% |
| 2023 Q1 | 97.45 Million CNY | 41.14% |
| 2023 Q4 | 96.07 Million CNY | 7.7% |
| 2023 Q3 | 89.2 Million CNY | -10.98% |
| 2023 Q2 | 100.2 Million CNY | 2.82% |
| 2023 FY | 382.93 Million CNY | 40.27% |
| 2022 Q1 | 68.74 Million CNY | 43.55% |
| 2022 FY | 273 Million CNY | 52.17% |
| 2022 Q4 | 69.04 Million CNY | -0.04% |
| 2022 Q3 | 69.07 Million CNY | 4.43% |
| 2022 Q2 | 66.14 Million CNY | -3.79% |
| 2021 FY | 179.4 Million CNY | 102.03% |
| 2021 Q4 | 47.89 Million CNY | 6.53% |
| 2021 Q3 | 44.95 Million CNY | 5.12% |
| 2021 Q2 | 42.76 Million CNY | -2.35% |
| 2021 Q1 | 43.79 Million CNY | 65.69% |
| 2020 FY | 88.8 Million CNY | 246.98% |
| 2020 Q3 | 31.66 Million CNY | 60.05% |
| 2020 Q1 | 10.92 Million CNY | 183.35% |
| 2020 Q2 | 19.78 Million CNY | 81.14% |
| 2020 Q4 | 26.43 Million CNY | -16.52% |
| 2019 Q2 | 16.68 Million CNY | 54.2% |
| 2019 FY | 25.59 Million CNY | 23.33% |
| 2019 Q3 | 11.18 Million CNY | -32.98% |
| 2019 Q4 | -13.1 Million CNY | -217.16% |
| 2019 Q1 | 10.82 Million CNY | 318.6% |
| 2018 Q3 | -8.8 Million CNY | -134.46% |
| 2018 FY | 20.75 Million CNY | -54.03% |
| 2018 Q2 | 25.54 Million CNY | 185.2% |
| 2018 Q4 | -4.95 Million CNY | 43.77% |
| 2018 Q1 | 8.95 Million CNY | 253.36% |
| 2017 Q4 | -5.84 Million CNY | -309.69% |
| 2017 Q3 | 2.78 Million CNY | -92.63% |
| 2017 Q1 | 10.39 Million CNY | 575.4% |
| 2017 FY | 45.14 Million CNY | -37.32% |
| 2017 Q2 | 37.8 Million CNY | 263.84% |
| 2016 Q2 | 34.25 Million CNY | 47.7% |
| 2016 FY | 72.02 Million CNY | -15.04% |
| 2016 Q4 | -2.18 Million CNY | -113.04% |
| 2016 Q1 | 23.18 Million CNY | 104.71% |
| 2016 Q3 | 16.76 Million CNY | -51.05% |
| 2015 Q4 | 11.32 Million CNY | -39.49% |
| 2015 FY | 84.77 Million CNY | -17.84% |
| 2015 Q3 | 18.72 Million CNY | -41.69% |
| 2015 Q2 | 32.1 Million CNY | 41.92% |
| 2015 Q1 | 22.62 Million CNY | -24.28% |
| 2014 Q4 | 29.87 Million CNY | 15.32% |
| 2014 Q3 | 25.9 Million CNY | -9.48% |
| 2014 FY | 103.18 Million CNY | 27.39% |
| 2014 Q1 | 18.78 Million CNY | -9.64% |
| 2014 Q2 | 28.61 Million CNY | 52.35% |
| 2013 Q4 | 20.78 Million CNY | -4.36% |
| 2013 FY | 80.99 Million CNY | 30.64% |
| 2013 Q3 | 21.73 Million CNY | -8.22% |
| 2013 Q2 | 23.68 Million CNY | 60.12% |
| 2013 Q1 | 14.79 Million CNY | -1.19% |
| 2012 Q4 | 14.96 Million CNY | -9.35% |
| 2012 Q3 | 16.51 Million CNY | -12.79% |
| 2012 Q2 | 18.93 Million CNY | 63.4% |
| 2012 FY | 62 Million CNY | 21.75% |
| 2012 Q1 | 11.58 Million CNY | -3.79% |
| 2011 Q3 | 13.26 Million CNY | -25.07% |
| 2011 Q1 | 7.92 Million CNY | -27.29% |
| 2011 Q2 | 17.69 Million CNY | 123.45% |
| 2011 Q4 | 12.04 Million CNY | -9.18% |
| 2011 FY | 50.92 Million CNY | 22.79% |
| 2010 FY | 41.47 Million CNY | 31.32% |
| 2010 Q4 | 10.89 Million CNY | -5.12% |
| 2010 Q2 | 13.69 Million CNY | 153.54% |
| 2010 Q3 | 11.48 Million CNY | -16.17% |
| 2010 Q1 | 5.4 Million CNY | 0.0% |
| 2009 FY | 31.58 Million CNY | 89.78% |
| 2008 FY | 16.64 Million CNY | 19.78% |
| 2007 FY | 13.89 Million CNY | 0.0% |